Whalegun
Home

Travere Therapeutics TVTX paid 2359 Strategies $22.5K for lobbying in Q4 2023 · Medicare, Health Issues and 3 more issues

Trade details

Type
Lobbying report
Amount
$22,500
Quarter
Q4 2023
Stock
Travere Therapeutics TVTX
Client
Travere Therapeutics
Reported
23/12/30

Up 0.0% from last quarter

What else happened in Travere Therapeutics around then

Filed or reported within 30 days of the trade day · 23/12/01~24/01/30

Travere Therapeutics's other lobbying reports

  • Travere Therapeutics

    LobbyingTravere Therapeutics

    $16K

    Reported 08/04

  • Travere Therapeutics

    LobbyingTravere Therapeutics

    $70K

    Reported 07/20

  • Travere Therapeutics

    LobbyingTravere Therapeutics

    $140K

    Reported 07/20

  • Travere Therapeutics

    LobbyingTravere Therapeutics

    $16K

    Reported 05/19

  • Travere Therapeutics

    LobbyingTravere Therapeutics

    $80K

    Reported 04/20

Travere Therapeutics TVTX paid 2359 Strategies $22.5K for lobbying in Q4 2023 · Medicare, Health Issues and 3 more issues | Whalegun